Clinical Trials Directory

Trials / Completed

CompletedNCT04997525

Estradiol and Progesterone Levels Following Frozen Embryo Transfer

Estradiol and Progesterone Levels in Early Pregnancy After Natural, Estradiol + Progesterone or Gonadotrophin Stimulated Frozen Embryo Transfer Cycle

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
305 (actual)
Sponsor
Copenhagen University Hospital at Herlev · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The aim of the present study is to investigate serum estradiol and progesterone levels in women conceiving after natural, estradiol + progesterone or gonadotropin stimulated frozen embryo transfer (FET) cycles.

Detailed description

Enrolled women will be randomized based on their ovulation pattern. Ovulatory women will be randomized to either natural cycle or estradiol + progesterone substituted cycle treatment for FET. Anovulatory women will be randomized to either estradiol + progesterone substituted cycle or gonadotropin stimulated cycle treatment for FET. Included women will undergo blood testing every two weeks for serum estradiol and progesterone levels until gestational age 9+6. Routine vaginal ultrasounds will be performed as well as additional pregnancy ultrasounds. Secondary obstetric outcomes will be investigated using the womens medical journals. All the treatments are considered standard treatments for FET.

Conditions

Interventions

TypeNameDescription
DRUGEstradiol TabletsCombined with progesterone
DRUGProgesteroneCombined with estradiol
DRUGFollitropin AlfaCombined with hCG
DRUGChorionic Gonadotropin, AlphaIn either natural cycle or combined with Follitropin Alfa

Timeline

Start date
2021-04-20
Primary completion
2024-05-07
Completion
2024-12-06
First posted
2021-08-09
Last updated
2025-01-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04997525. Inclusion in this directory is not an endorsement.